Europe - Euronext Milan - BIT:1MDT - IE00BTN1Y115 - Common Stock
The current stock price of 1MDT.MI is 89.1 EUR. In the past month the price increased by 10.95%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 18.23 | 112.91B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 18.21 | 49.08B | ||
| 1PHIA.MI | KONINKLIJKE PHILIPS NV | 16.59 | 23.65B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 15.73 | 22.42B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 15.72 | 22.41B | ||
| BIM.PA | BIOMERIEUX | 27.15 | 12.40B | ||
| OBCK.DE | OTTOBOCK SE & CO KGAA | 152.13 | 4.58B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 25.4 | 3.89B | ||
| DIA.MI | DIASORIN SPA | 18.8 | 3.48B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 10.57 | 1.28B | ||
| DRW8.DE | DRAEGERWERK AG | 9.58 | 1.16B | ||
| ELN.MI | EL.EN. SPA | 20.39 | 1.05B |
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
MEDTRONIC PLC
Building Two Parkmore Business Park West
DUBLIN DUBLIN IE
Employees: 95000
Phone: 1135314381700
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
The current stock price of 1MDT.MI is 89.1 EUR. The price increased by 2.06% in the last trading session.
MEDTRONIC PLC (1MDT.MI) has a dividend yield of 2.7%. The yearly dividend amount is currently 2.39.
1MDT.MI has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
The PE ratio for MEDTRONIC PLC (1MDT.MI) is 18.45. This is based on the reported non-GAAP earnings per share of 4.83 and the current share price of 89.1 EUR.
MEDTRONIC PLC (1MDT.MI) currently has 95000 employees.
MEDTRONIC PLC (1MDT.MI) will report earnings on 2026-02-17, before the market open.
ChartMill assigns a technical rating of 4 / 10 to 1MDT.MI.
ChartMill assigns a fundamental rating of 5 / 10 to 1MDT.MI. 1MDT.MI has an average financial health and profitability rating.
Over the last trailing twelve months 1MDT.MI reported a non-GAAP Earnings per Share(EPS) of 4.83. The EPS increased by 7.24% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 13.71% | ||
| ROA | 5.22% | ||
| ROE | 9.79% | ||
| Debt/Equity | 0.57 |
39 analysts have analysed 1MDT.MI and the average price target is 88.1 EUR. This implies a price decrease of -1.12% is expected in the next year compared to the current price of 89.1.
For the next year, analysts expect an EPS growth of 3.31% and a revenue growth 7.02% for 1MDT.MI